DIAGNOPLEX

Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rรยผf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as well as its high sensitivity and specificity.
DIAGNOPLEX
Social Links:
Industry:
Biotechnology Medical Device
Founded:
2005-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.diagnoplex.com
Total Employee:
1+
Status:
Active
Contact:
+41 21 989 20 00
Email Addresses:
[email protected]
Total Funding:
9.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon GoDaddy DNS OpenResty Google Adsense AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Initiative Capital Romandie
Initiative Capital Romandie investment in Venture Round - Diagnoplex
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Venture Round - Diagnoplex
Neomed Management
Neomed Management investment in Venture Round - Diagnoplex
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Diagnoplex
Neomed Management
Neomed Management investment in Series A - Diagnoplex
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Diagnoplex
Official Site Inspections
http://www.diagnoplex.com
- Host name: a2b7bf3398455f345.awsglobalaccelerator.com
- IP address: 99.83.161.153
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "Diagnoplex"
Diagnoplex - Crunchbase Company Profile & Funding
Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert โฆSee details»
Diagnoplex - Company Profile - Tracxn
Feb 20, 2025 Diagnoplex - Molecular diagnostics for colorectal cancer.. Acquired by Novigenix. Raised a total funding of $9.68M over 3 rounds from 4 investors. Founded by Stavros โฆSee details»
Diagnoplex - VentureRadar
Diagnoplex is a molecular diagnostics company with the objective of developing and commercializing a portfolio of tests for the early detection of various cancers. Diagnoplexโs โฆSee details»
Diagnoplex SA - Company Profile and News - Bloomberg Markets
Company profile page for Diagnoplex SA including stock price, company news, executives, board members, and contact informationSee details»
Diagnoplex - Raised $9.68M Funding from 4 investors - Tracxn
Mar 9, 2025 Diagnoplex has raised a total funding of $9.68M over 3 rounds from 4 investors. Investors include Novartis Venture Fund, NeoMed and 2 others. Their latest funding round โฆSee details»
Diagnoplex - Products, Competitors, Financials, Employees, โฆ
Diagnoplex's lead product, Colox, is a convenient and minimally-invasive blood test developed for the systematic screening of colorectal cancer. The gene signature underlying Colox has been โฆSee details»
Curzio Ruegg โ Chief Executive Officer โ Xemperia | LinkedIn
He is member of numerous national and international scientific committees and advisory boards (eg. SNSF, DFG, INSERM, SKL, CRUK, UICC, IARC, BIOS+,โฆ) and member of the Senate โฆSee details»
DIAGNOPLEX Trademark - Registration Number 4427038 - Serial โฆ
Blood for medical purposes; blood plasma; reagents for medical or veterinary use. Measuring and checking apparatus and instruments, namely, thermocyclers, for DNA and RNA quantification; โฆSee details»
Diagnoplex S.A. - BioCentury Company Profiles - BCIQ
Diagnoplex S.A. - BioCentury Company Profiles for the biopharma industrySee details»
Diagnoplex SA | Insights
Nov 6, 2013 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Diagnoplex Closes a Financing Round Led by Debiopharm โฆ
Jun 7, 2013 Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of โฆSee details»
Diagnoplex and Unilabs sign agreement to market colon cancer โฆ
Register and get more services Create your personal archive Get the Newsletter Set award alarms. Get involvedSee details»
News - University of Fribourg - Colon cancer: new screening test
Researchers at the University of Fribourg have developed a test enabling the early detection of colorectal cancer by means of a blood test. The test was developed in collaboration with โฆSee details»
Novartis Services Inc investment in Diagnoplex Sarl ()
Add your company. If your company is not in the database, create an account and, once logged in, add it by selecting "Add" > "Add company" in order to create a profile.See details»
Unilabs and Diagnoplex SA Announce the Swiss Market Launch of โฆ
Feb 28, 2014 Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe and Diagnoplex SA, a developer of molecular diagnostics for colorectal โฆSee details»
(PDF) Organizational Diagnosis: An Evidence-based Approach
Jan 1, 2012 Organizational diagnosis plays a critical role in organizational change initiatives in terms of both choosing appropriate interventions and contributing to readiness-to-change โฆSee details»
Organizational Diagnostic & Employee Wellbeing Solutions
Work in an organization that prioritizes employee success and mental health. Provide Feedback That Matters. Employee insights shape real organizational changeโyour input drives action. โฆSee details»
Expert Cancer Detection | Previse
Esophageal cancer is a global concern. In 2025, an estimated 22,070 people will be diagnosed with esophageal cancer in the United States and about 16,250 people will die from the disease โฆSee details»
Category : Music Files (Naming and Organizing) | Plex Support
Plex and our partners use standard Web technologies, such as browser cookies, which may be necessary to make our site work and enable core functionality, such as security, network โฆSee details»
Tag support for ROBUST music library organization
Jun 16, 2015 This is a request for comprehensive support of the ID3/Vorbis/etc. tags that are necessary for truly meaningful and complete organization of music libraries, both classical and โฆSee details»